Bill Title: Reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.

Sponsorship: Slight Partisan Bill (Republican 9-4)

Status: (Passed) 2026-03-10 - Signed by the Governor on March 10, 2026 H.J. 547 [HB1099 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
Enrolled	2026-03-03	PDF	Link	View
Introduced	2026-01-20	PDF	Link	View

Amendments

Amendment	Date	Disposition	Format	Source	View
No bill amendments currently on file for South Dakota HB1099

Supplemental Documents

Title	Description	Date	Format	Source	View
No supplemental documents for South Dakota HB1099 currently on file.